IRIS
CELESIA, BENEDETTO MAURIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.016
AS - Asia 1.503
EU - Europa 1.261
SA - Sud America 295
AF - Africa 198
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.280
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.933
SG - Singapore 760
CN - Cina 498
IT - Italia 441
BR - Brasile 264
IE - Irlanda 260
DE - Germania 143
UA - Ucraina 135
CI - Costa d'Avorio 122
IN - India 80
FI - Finlandia 79
CA - Canada 62
KR - Corea 58
RU - Federazione Russa 45
SN - Senegal 40
GB - Regno Unito 33
VN - Vietnam 29
SE - Svezia 27
NG - Nigeria 20
NL - Olanda 20
HK - Hong Kong 19
MX - Messico 15
PL - Polonia 14
BE - Belgio 13
BD - Bangladesh 11
AT - Austria 10
FR - Francia 10
AR - Argentina 9
CH - Svizzera 8
CO - Colombia 7
EC - Ecuador 7
IQ - Iraq 7
TR - Turchia 7
AU - Australia 5
JP - Giappone 5
KE - Kenya 5
ZA - Sudafrica 5
CZ - Repubblica Ceca 4
ES - Italia 4
GR - Grecia 4
SA - Arabia Saudita 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
LB - Libano 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BH - Bahrain 2
DK - Danimarca 2
IR - Iran 2
JM - Giamaica 2
KG - Kirghizistan 2
LT - Lituania 2
MA - Marocco 2
NP - Nepal 2
PK - Pakistan 2
TN - Tunisia 2
BB - Barbados 1
BO - Bolivia 1
BS - Bahamas 1
CL - Cile 1
CR - Costa Rica 1
DM - Dominica 1
ET - Etiopia 1
EU - Europa 1
ID - Indonesia 1
JO - Giordania 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MW - Malawi 1
NR - Nauru 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 6.280
Salva come PNG Salva come JPEG
Città #
Santa Clara 615
Singapore 515
Chandler 378
Dallas 326
Dublin 259
Chicago 157
Jacksonville 150
Hefei 125
Abidjan 122
Boardman 113
Beijing 108
Los Angeles 101
Catania 100
Munich 89
Ashburn 78
New York 65
Cambridge 64
Lawrence 64
Seoul 58
Civitanova Marche 57
Andover 55
Helsinki 50
Kochi 48
Dakar 40
Toronto 40
Des Moines 35
Nanjing 34
Nanchang 25
Rome 24
São Paulo 23
Wilmington 22
Abuja 20
The Dalles 20
Columbus 18
Hong Kong 18
Lappeenranta 15
Milan 15
San Mateo 15
Modica 14
Brussels 13
Boston 12
Brooklyn 12
Grafing 12
Philadelphia 12
Rende 12
Shenyang 12
Warsaw 12
Bremen 11
Changsha 11
Dong Ket 11
Jiaxing 11
Milazzo 11
Palermo 11
Tremestieri Etneo 11
Hebei 10
Houston 10
Ottawa 10
Rio de Janeiro 10
Atlanta 9
Council Bluffs 9
Mumbai 9
Saint Petersburg 9
San Francisco 8
Tianjin 8
Turku 8
London 7
Montreal 7
Redwood City 7
Seattle 7
Amsterdam 6
Brasília 6
Chennai 6
Hanoi 6
Mexico City 6
Reggio Emilia 6
Augusta 5
Charlotte 5
Curitiba 5
Jinan 5
Nairobi 5
Norwalk 5
Phoenix 5
Salvador 5
San Giovanni la Punta 5
Tramonti 5
Bari 4
Carrara 4
Falls Church 4
Genoa 4
Guarulhos 4
Ho Chi Minh City 4
Jyväskylä 4
Kunming 4
Moscow 4
Scordia 4
Shanghai 4
Sydney 4
Tokyo 4
Zhengzhou 4
Anápolis 3
Totale 4.522
Salva come PNG Salva come JPEG
Nome #
"Diagnosis on the Dock" project: a proactive screening program for diagnosing pulmonary tuberculosis in disembarking refugees and new SEI model 252
Clinical characteristics and predictors of death among hospitalized patients infected with SARS‑CoV‑2 in Sicily, Italy: A retrospective observational study 103
Long-Term Survivors in a Cohort of People Living with HIV Diagnosed between 1985 and 1994: Predictive Factors Associated with More than 25 Years of Survival 100
A measles outbreak in Catania, Sicily: the importance of high vaccination coverage and early notification of cases for health and economic reasons 94
Atypical Presentation of PKDL due to Leishmania infantum in an HIV-Infected Patient with Relapsing Visceral Leishmaniasis 91
Circulating angiopoietin-like protein 2 levels are associated with decreased renal function in HIV+ subjects on cART: A potential marker of kidney disease 91
[In Process Citation] 90
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus. 88
Antiretroviral therapy in geriatric HIV patients: The GEPPO cohort study 87
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL 85
Baseline CD4/CD8 T-cell Ratio Predicts Prompt Immune Restoration upon cART Initiation 84
HCV and HBV infection among multitransfused thalassemics from eastern Sicily 80
Influence of hepatitis G virus coinfection on the clinical course of chronic hepatitis C 80
Long-term survivors in a cohort of HIV+ patients diagnosed between 1985 and 1992: predictive factors associated with more than 25 years of survival 80
Navigating the Nexus: HIV and Breast Cancer—A Critical Review 79
Efficacy and safety of Atazanavir/Ritonavir therapy in a cohort of treatment-experienced patients 79
Severe Neutropenia after Sarilumab Administration in Two COVID-19 Patients: Case Reports and Literature Review 78
Preliminary investigation on intrafamilial spread of hepatitis C virus (HCV) 78
Factors predicting tuberculosis reactivation in HIV-infected patients [PARAMETRI PREDITTIVI DI RIATTIVAZIONE TUBERCOLARE IN SOGGETTI CON INFEZIONE DA HIV] 78
Could we consider the intima-media thickness (c-IMT)> 1 mm as a risk factor for cardiovascular diseases in HIV plus subjects chronically treated with antiretrovirals? 78
Hepatic echinococcosis: clinical and therapeutic aspects 76
Kidney disease in HIV-infected patients 75
Editorial-Coronavirus disease 2019 and people living with HIV: Clinical considerations 75
HIV Infection Diagnosis in a Late Presenter Patient during a Severe Imported Falciparum Malaria: A Challenging 75
Valutazione di parametri immunologici e virologici in soggetti con infezione da HIV-1 sottoposti a terapia HAART affetti da Leishmaniosi viscerale recidivante 75
Cryptococcal meningitis in an HIV-1-infected person: relapses or IRIS? Case report and review of the literature 74
Entecavir resistance in a patient with treatment‑naïve HBV: A case report 74
Is it safe and cost saving to defer the CD4+ cell count monitoring in stable patients on ART with more than 350 or 500 cells/µL? 72
Sifilide ed HIV.Presentazione di tre casi clinici 72
Heel quantitative ultrasound in HIV-infected patients: a cross-sectional study 71
The first report of HTLV-I infection associated with blood transfusion in a thalassemic patient from Sicily, Italy 71
Ruolo del rapporto eterosessuale nella trasmissione dell’infezione HIV in un gruppo di tossicodipendenti della Sicilia Orientale. Necessità di modificare le strategie di prevenzione? 70
Trimethoprim-sulfamthoxazole associated severe hypoglicemia: a sulfnylurea like effect 70
Valutazione di parametri immunologici e virologici in soggetti con infezione da HIV-1 sottoposti a terapia HAART affetti da Leishmaniosi viscerale recidivante 69
Non-AIDS defining cancers: a comprehensive update on diagnosis and management 66
Post-infectious ST elevation myocardial infarction following a COVID-19 infection: A case report 66
High-flow nasal cannula oxygenation and tocilizumab administration in patients critically ill with COVID-19: A report of three cases and a literature review 64
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 64
Hepatitis B virus infection and hepatocellular carcinoma in PLWH: epidemiology, pathogenesis and treatment 64
Loco-Regional Treatments for Hepatocellular Carcinoma in People Living with HIV 64
Successful extracorporeal membrane oxygenation treatment in an acquired immune deficiency syndrome (AIDS) patient with acute respiratory distress syndrome (ARDS) complicating pneumocystis jirovecii pneumonia: A challenging case 64
Serum tumor necrosis factor in acute and fulminant hepatitis B 63
Immunological and Clinical Impact of DAA-Mediated HCV Eradication in a Cohort of HIV/HCV Coinfected Patients: Monocentric Italian Experience 61
Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World Cohort 60
Modification of Serum Brain-Derived Neurotrophic Factor Levels Following Anti-HCV Therapy with Direct Antiviral Agents: A New Marker of Neurocognitive Disorders 60
Anxiety disorders and adherence to HAART 59
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study 59
Possible role of low dose dexamethasone administration in listeria monocytogenes meningoencephalitis: A case series 59
Rare case of Rhodococcus hoagii bacteremia in an HIV late‑presenter with NTM pulmonary disease: A case report and review of the literature 58
Analysis of impediments to the maintenance in care of people with HIV in Italy 58
Laryngeal leishmaniasis in a HIV‑positive patient: A case report and review of the literature 57
Localizzazione osteoarticolare multipla in corso di sepsi da Staphylococcus aureus meticillino-resistente: Considerazioni clinico- terapeutiche [Multiple osteo-articular involvement due to methicillin-resistant Staphylococcus aureus septicaemia: clinical and therapeutic evaluation] 57
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 57
Pain crisis management in a patient with sickle cell disease during SARS‑CoV‑2 infection: A case report and literature review 56
LPS and HIV gp120 modulate monocyte/macrophage CYP27B1 and CYP24A1 expression leading to vitamin D consumption and hypovitaminosis D in HIV-infected individuals 55
Thyroid Diseases and Thyroid Asymptomatic Dysfunction in People Living With HIV 54
Enhanced metabolic health and immune response with bictegravir/emtricitabine/TAF: Insights from a 96-week retrospective study 54
Late presentation of HIV infection: predictors of delayed diagnosis and survival in Eastern Sicily 54
Sarilumab administration in patients with severe COVID‑19: A report of four cases and a literature review 54
Microbial translocation in chronic liver diseases 53
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) 53
Diagnosis, Treatment, and Prevention of HIV Infection among Detainees: A Review of the Literature 51
HCV and HIV infection among intravenous drug abusers in eastern Sicily 51
High prevalence of undiagnosed anxiety symptoms among HIV-positive individuals on cART: A cross-sectional study 51
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART 51
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: results a large multicentre observational prospective cohort (SCOLTA) 50
Predictive criteria of sustained virological response (more than 60 months) to Nevirapine-based antiretroviral treatment 50
Prolonged Th2 cell activation and increased viral replication in HIV-Leishmania co-infected patients despite treatment 48
Long-acting drugs: people's expectations and physicians' preparedness. Are we readying to manage it? An Italian survey 47
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 45
Prevalenza e distribuzione dell’HHV-8 in differenti popolazioni con e senza infezione da HIV 44
Entangled Connections: HIV and HPV Interplay in Cervical Cancer—A Comprehensive Review 43
Serum cytokines as predictors of clinical outcome in AIDS-related intestinal cryptosporidiosis 43
Prevalence of HLA-B*5701 and access to genetic test in Sicily. A multicenter study 42
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data from the PRESTIGIO Registry 42
Atherosclerosis and Cardiovascular Complications in People Living with HIV: A Focused Review 41
Sexual dysfunction in HIV plus subjects in eastern Sicily 41
Test for CCR5 tropism and treatment with maraviroc in Sicily: an observational retrospective multicentre study 41
Valutazione di parametri immunologici e virologici in soggetti con infezione da HIV-1 sottoposti a terapia HAART affetti da Leishmaniosi viscerale recidivante 40
Pulmonary Kaposi Sarcoma without Respiratory Symptoms and Skin Lesions in an HIV-Naïve Patient: A Case Report and Literature Review 40
New HIV diagnosis and linkage to care in two outpatient units in South Europe 39
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 38
Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy 37
Porphyria cutanea tarda in an HIV-1-infected patient after the initiation of tipranavir/ritonavir: case report 35
Evaluation of HIV transmission cluster among natives and foreigners living Italy 34
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 33
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 30
Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: A Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians 30
Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 29
PrEP in Italy: The time may be ripe but who’s paying the bill? A nationwide survey on physicians’ attitudes towards using antiretrovirals to prevent HIV infection 26
Factors associated with weight gain in people treated with dolutegravir 26
Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus 25
Weight gain: A possible side effect of all antiretrovirals 25
Enhanced immunological recovery with early start of antiretroviral therapy during acute or early HIV infection–results of Italian network of acute HIV infection (Inaction) retrospective study 25
Ageing with HIV: a multidisciplinary review 25
Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial 25
Safety and tolerability of Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 25
Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir 24
Archi-Prevaleat project. A national register of color-doppler ultrasonography of the epi-aortic vessels in patients living with HIV 24
Viro-Immunological Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide among Women Living with HIV: A 96-Week Post-Switch Analysis from the Real-Life SHiNe-SHiC Cohort 20
Totale 5.923
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.403
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.403
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021295 0 0 47 7 69 14 29 0 35 24 52 18
2021/2022469 39 61 12 5 65 8 72 27 46 11 20 103
2022/20231.035 71 67 14 101 106 171 5 177 245 5 40 33
2023/2024496 28 63 21 32 22 135 5 35 4 22 79 50
2024/20252.656 25 287 110 104 567 334 92 86 236 276 293 246
2025/20261.166 382 380 404 0 0 0 0 0 0 0 0 0
Totale 6.502